This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this episode, we sit down with Sara Schweitzer , a passionate recruiter in Stryker’s spine division, whose journey into medical sales and recruiting is anything but ordinary. 01:00 This is a Stryker recruiter coming at. You live deep in the action of recruiting for Stryker and she’s in the spine division.
A white paper by Medable shares some insights on how companies can leverage eConsent to improve clinical trial recruitment and retention. As life science companies seek to boost clinical trial participation, eConsent forms can pose a stumbling block.
The potential for reaching a larger pool of recruits is possible when sponsors can bring more trial activities to the patient. There’s been a rapid shift towards decentralization in clinical trials & it’s clear why.
By allowing study teams to design and conduct more inclusive and/or relevant studies, real-world data can enhance the standard of care and ultimately improve patient outcomes.
A panel at the MedCity News INVEST conference in Dallas discussed how new tech platforms help speed up the process of recruitingpatients and running clinical trials. AI technologies have a role in the life sciences that goes beyond drug discovery.
with the right technology, healthcare organizations in the year ahead can become more efficient, make quality care accessible to more people, reduce their recruiting and hiring costs, prevent mistakes, and deliver better outcomes for themselves, their workers and their patients.
By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.
In response to recent FDA guidelines which limit the nitrosamine content of drugs, Novartis has paused the enrollment of early breast cancer (eBC) patients in clinical trials of its blockbuster Kis | In response to recent FDA guidelines which limit the nitrosamine content of drugs, Novartis has paused the enrollment of early breast cancer (eBC) patients (..)
Somewhere over the last decade, the passionate people who believed that helping patients was the first step in excellent marketing have been replaced with people who want to know the ROI of everything. We need to hire people who have a passion for learning, exploring, and implementing great patient-centered marketing.
Pharma’s missing the mark when it comes to recruiting Black patients, and Ricki Fairley, CEO of The Black Breast Cancer Alliance, reveals what’s needed.
True patient engagement creates ripple effects that transform both clinical outcomes and business results in a measurable way. Measuring engagement isnt just about numbersits about the lives that are touched and the improvements made through strategic, thoughtful approaches to patient communication.
This month, former Territory Manager, Ketan Patel, joins the Recruitment Team. “I I hadn’t considered Recruitment before”, he says “but having spoken to both Sarah and Danny, they felt that I may be a good fit. Hi Ketan, first, tell us a little bit about you and the area you’re recruiting for.
DTC may or may not work for clinical trial enrollment it really depends on the condition and risk as judged by the patient. More than 40 million patients are needed to meet the demand of currently enrolling trials. More than 18,000 clinical trials are actively recruitingpatients in the U.S. According to antidote.com.
Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. Instead, atopic dermatitis clinical trial organisers often simply only reach out to a limited patient population and fail to reach the complete, diverse, patient population of atopic dermatitis.
Recruit a new type of healthcare employee – often a person who is seeking to change careers to a more dynamic and higher paying field. Hospitals can utilize this approach to begin to augment the role of the nurse, and start to recruit recent high school graduates or those from other industries looking for a new career.
Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of volunteers into clinical trials, aiming to solve a major obstacle in clinical research.Patient recruitment remains a major challenge for trial sponsors and can lead to delays and increased costs, and traditional methods can be time-consuming (..)
A French pharmaceutical team contacted Impetus Digital to help them establish a Virtual Steering Committee for patients with HIV/AIDS. They wanted to find a way to directly involve patients in driving strategy development and ensure that the patient voice is reflected in all of their patient-facing educational and support materials.
In-house medical recruiters play a critical role in healthcare organizations, ensuring that hospitals and clinics are staffed with qualified professionals. However, behind the scenes, these recruiters face a multitude of challenges that can often lead to frustration, burnout, and inefficiency. What is an In-House Medical Recruiter?
A thirteen-year-old patient with relapsed T-cell acute lymphoblastic leukaemia (T-ALL) has been the first to be treated with base-edited T-cells via CD7 Chimeric Antigen Receptor (CAR)-T cell therapy, which enabled them to achieve remission 28 days later. . Six months later, the patient is doing well and is recovering at home.
One definition of patient-centricity is “Putting the patient first in an open and sustained engagement of the patient to respectfully and compassionately achieve the best experience and outcome for that person and their family” ( Yeoman et al. A version of this article was previously published in the Journal of mHealth.
Micropayments provide an additional incentive for patients to complete required tests, procedures, and diary entries, ensuring that sites, sponsors, and CROs are able to collect the required data needed to complete a clinical trial on time and on budget.
Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. See Full Press Release at the Source: Sonorous NV Uses New Device to Treat Patients with Symptomatic Cerebral Venous Diseases. Sonorous NV, Inc.
— Watch the episode here Listen to the podcast here Surviving Cancer And Making An Impact To Cancer Patients’ Lives With Rob Ciaramitaro In this episode, we have with us another special guest and he goes by the name of Rob Ciaramitaro. Diagnostic products can change when patients discover their diseases.
The evolution of clinical research has been dependent on the conversion of Healthcare Organizations (HCOs) to clinical research sites, along with the conversion of Healthcare Providers (HCPs) to Pr | Effective site enablement must address several factors, including protocol design, training, patientrecruitment and enrollment, and more.
took a step towards its vision of transforming chronic care management with Polso , the company’s Remote Patient Monitoring (RPM) solution, achieving 510(k) clearance from the U.S. trillion in direct healthcare costs annually1, there is a serious need for an easy-to-use , medical grade, remote patient monitoring solution.”
Regulators and health technology assessment (HTA) bodies are increasingly demanding the patient voice play a central role in drug development – making it riskier for developers to ignore the need for engagement than to embrace it. The patient centricity movement has been building momentum in recent years. Building relevance.
The last few years, both during and after the pandemic, have been turbulent times for healthcare providers and patients alike. For now, although it appears that healthcare staffing shortages will continue, providers are not without practical strategies for attracting and retaining talent.
Whether for recruitment, marketing, or patient care coordination, leveraging a list of doctors in Nova Scotia ensures precision in decision-making and strengthens healthcare networks. Streamlined Access to Physician Data Nova Scotia’s healthcare system requires adequate help to cope.
Face-to-face discussion educates regulators on what matters most to patients, and guides future decision-making. Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. The rise of patient centricity. “We
The strict regulatory requirements within the healthcare ecosystem mandate that IDP systems ensure patient privacy protection and maintain audit trails. For example, it’s possible to analyze scheduled assessments for a patient to find out what is involved for the patient.
announced that over 1,200 patients have been treated with the Early Bird® Bleed Monitoring System, the first and only FDA-approved bleed detection system. The adoption of the Early Bird system is a testimony to physicians embracing the benefits of early bleed detection for their patients and practice.”. “We Saranas, Inc.
Recently, industry and community patient advocacy pioneers came together for the Chief Patient Officer Summit. Though the title is rare, having a leader highly placed within a biopharmaceutical company solely responsible for integrating patient perspectives is no longer Pollyanna. That was 2014. Succeeding Internally.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content